Found: 7
Select item for more details and to access through your institution.
Letter: biologics treatment in Crohn's disease and risk of bowel resection-what about the patients who stop anti- TNF therapy? Authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2018, v. 47, n. 1, p. 147, doi. 10.1111/apt.14398
- By:
- Publication type:
- Article
Anti- TNF treatment in Crohn's disease and risk of bowel resection-a population based cohort study.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2017, v. 46, n. 6, p. 589, doi. 10.1111/apt.14224
- By:
- Publication type:
- Article
Prolonged elevation of plasma HMGB1 is associated with cognitive impairment in intensive care unit survivors.
- Published in:
- 2020
- By:
- Publication type:
- letter
Inflammatory bowel disease and psoriasis: modernizing the multidisciplinary approach.
- Published in:
- Journal of Internal Medicine, 2021, v. 290, n. 2, p. 257, doi. 10.1111/joim.13282
- By:
- Publication type:
- Article
Evidence for Immunosurveillance in Intestinal Premalignant Lesions.
- Published in:
- Scandinavian Journal of Immunology, 2010, v. 71, n. 5, p. 362, doi. 10.1111/j.1365-3083.2010.02377.x
- By:
- Publication type:
- Article
Altered immunoregulatory profile during anti-tumour necrosis factor treatment of patients with inflammatory bowel disease.
- Published in:
- Clinical & Experimental Immunology, 2012, v. 169, n. 2, p. 137, doi. 10.1111/j.1365-2249.2012.04600.x
- By:
- Publication type:
- Article
The mode of actions of the Adacolumn therapeutic leucocytapheresis in patients with inflammatory bowel disease: a concise review.
- Published in:
- Clinical & Experimental Immunology, 2011, v. 163, n. 1, p. 50, doi. 10.1111/j.1365-2249.2010.04279.x
- By:
- Publication type:
- Article